{"id":"https://openalex.org/W3082878050","doi":"https://doi.org/10.1124/jpet.120.000185","title":"A Novel Potent and Selective Histamine H3 Receptor Antagonist Enerisant: In Vitro Profiles, In Vivo Receptor Occupancy, and Wake-Promoting and Procognitive Effects in Rodents","display_name":"A Novel Potent and Selective Histamine H3 Receptor Antagonist Enerisant: In Vitro Profiles, In Vivo Receptor Occupancy, and Wake-Promoting and Procognitive Effects in Rodents","publication_year":2020,"publication_date":"2020-08-29","ids":{"openalex":"https://openalex.org/W3082878050","doi":"https://doi.org/10.1124/jpet.120.000185","mag":"3082878050","pmid":"https://pubmed.ncbi.nlm.nih.gov/32862143"},"language":"en","primary_location":{"id":"doi:10.1124/jpet.120.000185","doi":"https://doi.org/10.1124/jpet.120.000185","is_oa":true,"landing_page_url":"https://doi.org/10.1124/jpet.120.000185","pdf_url":"https://jpet.aspetjournals.org/content/jpet/375/2/276.full.pdf","source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jpet.aspetjournals.org/content/jpet/375/2/276.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019444525","display_name":"Noriko Hino","orcid":"https://orcid.org/0000-0002-6982-5444","observed_orcids":["https://orcid.org/0000-0002-6982-5444"]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Hino","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087182584","display_name":"Toshiyuki Marumo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiyuki Marumo","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064230085","display_name":"Makiko Kotani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makiko Kotani","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111583362","display_name":"Toshiharu Shimazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiharu Shimazaki","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068056465","display_name":"Ayaka Kaku-Fukumoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ayaka Kaku-Fukumoto","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070380347","display_name":"Hirohiko Hikichi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirohiko Hikichi","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110093370","display_name":"Jun-ichi Karasawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jun-ichi Karasawa","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083557423","display_name":"Yasumitsu Tomishima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasumitsu Tomishima","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053024926","display_name":"Hiroko Komiyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroko Komiyama","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049204135","display_name":"Emi Tatsuda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Emi Tatsuda","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039544077","display_name":"Dai Nozawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Dai Nozawa","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079574791","display_name":"Toshio Nakamura","orcid":"https://orcid.org/0000-0001-9500-1783","observed_orcids":["https://orcid.org/0000-0001-9500-1783"]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshio Nakamura","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039021133","display_name":"Shigeyuki Chaki","orcid":"https://orcid.org/0000-0003-4444-2911","observed_orcids":["https://orcid.org/0000-0003-4444-2911","https://orcid.org/0000-0001-5608-4192"]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeyuki Chaki","raw_affiliation_strings":["Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan s-chaki@taisho.co.jp","Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan s-chaki@taisho.co.jp","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I144245601"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":0.9469,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.71041675,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"375","issue":"2","first_page":"276","last_page":"285"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.6074000000953674,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.6074000000953674,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.1282999962568283,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0812000036239624,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histamine-h3-receptor-antagonists","display_name":"histamine H3 receptor antagonists","score":0.9070000052452087},{"id":"https://openalex.org/keywords/inverse-agonists","display_name":"inverse agonists","score":0.9139999747276306},{"id":"https://openalex.org/keywords/procognitive-effects","display_name":"procognitive effects","score":0.9729999899864197},{"id":"https://openalex.org/keywords/receptor-occupancy","display_name":"receptor occupancy","score":0.9629999995231628},{"id":"https://openalex.org/keywords/scopolamine-induced-cognitive-impairment","display_name":"scopolamine-induced cognitive impairment","score":0.8050000071525574},{"id":"https://openalex.org/keywords/social-recognition","display_name":"social recognition","score":0.6660000085830688},{"id":"https://openalex.org/keywords/novel-object-recognition","display_name":"novel object recognition","score":0.9739999771118164},{"id":"https://openalex.org/keywords/histamine-release","display_name":"histamine release","score":0.8209999799728394},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.7570000290870667},{"id":"https://openalex.org/keywords/acetylcholine","display_name":"acetylcholine","score":1.0},{"id":"https://openalex.org/keywords/histaminergic-neurons","display_name":"histaminergic neurons","score":0.7239999771118164},{"id":"https://openalex.org/keywords/arousal","display_name":"arousal","score":0.6549999713897705},{"id":"https://openalex.org/keywords/cognitive-enhancement","display_name":"cognitive enhancement","score":0.597000002861023},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.5120000243186951},{"id":"https://openalex.org/keywords/frontal-cortex","display_name":"frontal cortex","score":0.4620000123977661}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7339320182800293},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6710498929023743},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6136209964752197},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.603263258934021},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5845611691474915},{"id":"https://openalex.org/C1122143","wikidata":"https://www.wikidata.org/wiki/Q61233","display_name":"Histamine","level":2,"score":0.5509610772132874},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.5322347283363342},{"id":"https://openalex.org/C160331591","wikidata":"https://www.wikidata.org/wiki/Q7075743","display_name":"Occupancy","level":2,"score":0.4651193618774414},{"id":"https://openalex.org/C63180777","wikidata":"https://www.wikidata.org/wiki/Q288395","display_name":"Histamine H3 receptor","level":4,"score":0.45058342814445496},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4339229166507721},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.360110342502594},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3123384714126587},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29951322078704834},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13366514444351196},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.06113746762275696},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004569","descriptor_name":"Electroencephalography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006633","descriptor_name":"Histamine Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006633","descriptor_name":"Histamine Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008124","descriptor_name":"Locomotion","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014851","descriptor_name":"Wakefulness","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018100","descriptor_name":"Receptors, Histamine H3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018377","descriptor_name":"Neurotransmitter Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1124/jpet.120.000185","doi":"https://doi.org/10.1124/jpet.120.000185","is_oa":true,"landing_page_url":"https://doi.org/10.1124/jpet.120.000185","pdf_url":"https://jpet.aspetjournals.org/content/jpet/375/2/276.full.pdf","source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:32862143","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32862143","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1124/jpet.120.000185","doi":"https://doi.org/10.1124/jpet.120.000185","is_oa":true,"landing_page_url":"https://doi.org/10.1124/jpet.120.000185","pdf_url":"https://jpet.aspetjournals.org/content/jpet/375/2/276.full.pdf","source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3082878050.pdf","grobid_xml":"https://content.openalex.org/works/W3082878050.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W249845531","https://openalex.org/W1713261992","https://openalex.org/W1895515176","https://openalex.org/W1919779618","https://openalex.org/W1968532777","https://openalex.org/W1968695161","https://openalex.org/W1992813376","https://openalex.org/W1997262070","https://openalex.org/W2006141992","https://openalex.org/W2010469749","https://openalex.org/W2022628868","https://openalex.org/W2025195726","https://openalex.org/W2025552546","https://openalex.org/W2046411639","https://openalex.org/W2047886027","https://openalex.org/W2052889782","https://openalex.org/W2072008776","https://openalex.org/W2073023454","https://openalex.org/W2077476143","https://openalex.org/W2077687762","https://openalex.org/W2083551870","https://openalex.org/W2083847445","https://openalex.org/W2085658618","https://openalex.org/W2096162880","https://openalex.org/W2102773142","https://openalex.org/W2107675787","https://openalex.org/W2118388838","https://openalex.org/W2120641846","https://openalex.org/W2121477596","https://openalex.org/W2127601100","https://openalex.org/W2130900903","https://openalex.org/W2160161356","https://openalex.org/W2163815564","https://openalex.org/W2230382798","https://openalex.org/W2257594985","https://openalex.org/W2757271273","https://openalex.org/W2897015813","https://openalex.org/W2942146122","https://openalex.org/W3003702393","https://openalex.org/W3009627507","https://openalex.org/W3015973304","https://openalex.org/W6875145887","https://openalex.org/W6875628915"],"related_works":["https://openalex.org/W2040204696","https://openalex.org/W2596568665","https://openalex.org/W2127601100","https://openalex.org/W2020585914","https://openalex.org/W3206669669","https://openalex.org/W2397691790","https://openalex.org/W2170266710","https://openalex.org/W2077476143","https://openalex.org/W1968695161","https://openalex.org/W2107675787"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-09-08T00:00:00"}